New biomarkers sought to distinguish child arthritis types

NCT ID NCT03827759

Terminated Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Apr 28, 2026 · Last updated Apr 28, 2026

Summary

This study aimed to find new biological markers (like proteins and immune signals) in blood and joint fluid that can help doctors tell the difference between septic arthritis (caused by infection) and juvenile idiopathic arthritis (an inflammatory condition) in children. Researchers planned to analyze samples from 100 children under 15 with acute arthritis. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHU Montpellier - Pediatric emergencies

Montpellier, Hérault, 34295, France
CHU Nîmes - Pediatrics

Nîmes, 30029, France
CHU Toulouse - Pediatric infectious diseases

Toulouse, 31300, France
Hospices Civils de Lyon - pediatric rheumatology

Lyon, 69002, France
Hôpital Saint Joseph

Marseille, 13285, France

Conditions

Explore the condition pages connected to this study.

CHILDREN INFLAMMATORY ARTHRITIS SEPTIC ARTHRITIS